Showing results (231-240 of 265) with videos related to
Sort By:
Pageof 27
Clinical and Experimental Rheumatology|October 16, 2004
Clinical optimization and multicenter validation of antigen-specific cut-off values on the INNO-LIA ANA update for the detection of autoantibodies in connective tissue disordersH Pottel, A Wiik, H Locht, et al.Parasite Immunology|November 7, 2009
IL-4(-/-) mice with lethal Mesocestoides corti infections--reduced Th2 cytokines and alternatively activated macrophagesA E O'Connell, L A Kerepesi, G L Vandergrift, et al.Marine Drugs|September 23, 2014
An improved high yield total synthesis and cytotoxicity study of the marine alkaloid neoamphimedine: an ATP-competitive inhibitor of topoisomerase IIα and potent anticancer agentLinfeng Li, Adedoyin D Abraham, Qiong Zhou, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 21, 2021
Release of endogenous dynorphin opioids in the prefrontal cortex disrupts cognitionAntony D Abraham, Sanne M Casello, Selena S Schattauer, et al.Archives of Virology|March 1, 2018
Characterization of an Australian isolate of taro bacilliform virus and development of an infectious cloneDawit B Kidanemariam, Amit C Sukal, Kathy Crew, et al.Journal of Medicinal Chemistry|December 18, 2013
Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductaseLinfeng Li, Kun-Che Chang, Yaming Zhou, et al.The Biochemical Journal|August 15, 1984
The enzymic defect and storage products in canine fucosidosisD Abraham, W F Blakemore, A Dell, et al.Medicine and Science in Sports and Exercise|January 1, 1991
Physiological and biomechanical factors associated with elite endurance cycling performanceE F Coyle, M E Feltner, S A Kautz, et al.Physics and Imaging in Radiation Oncology|September 29, 2023
In silico trial of simulation-free hippocampal-avoidance whole brain adaptive radiotherapyAlex T Price, Kylie H Kang, Francisco J Reynoso, et al.Frontiers in Molecular Neuroscience|November 29, 2018
The Development of an AAV-Based CRISPR SaCas9 Genome Editing System That Can Be Delivered to Neurons in vivo and Regulated via Doxycycline and Cre-RecombinaseNamrata Kumar, William Stanford, Christopher de Solis, et al.Pageof 27